BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 23428854)

  • 1. Role of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the management of hepatocellular carcinoma: consensus at the Symposium of the 48th Annual Meeting of the Liver Cancer Study Group of Japan.
    Kudo M; Matsui O; Sakamoto M; Kitao A; Kim T; Ariizumi S; Ichikawa T; Kobayashi S; Imai Y; Izumi N; Fujinaga Y; Arii S
    Oncology; 2013; 84 Suppl 1():21-7. PubMed ID: 23428854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional nodules detected using EOB-MRI in patients with resectable single hepatocellular carcinoma: an implication for active treatment strategy.
    Kim NR; Rho SY; Navarro J; An C; Han DH; Choi JS; Kim MJ; Choi GH
    J Liver Cancer; 2024 Mar; 24(1):92-101. PubMed ID: 38351675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussion.
    Taouli B; Ba-Ssalamah A; Chapiro J; Chhatwal J; Fowler K; Kang TW; Knobloch G; Koh DM; Kudo M; Lee JM; Murakami T; Pinato DJ; Ringe KI; Song B; Tabrizian P; Wang J; Yoon JH; Zeng M; Zhou J; Vilgrain V
    Eur Radiol; 2023 Dec; 33(12):9167-9181. PubMed ID: 37439935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update.
    Kudo M; Matsui O; Izumi N; Iijima H; Kadoya M; Imai Y;
    Oncology; 2014; 87 Suppl 1():7-21. PubMed ID: 25427729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid).
    Jhaveri K; Cleary S; Audet P; Balaa F; Bhayana D; Burak K; Chang S; Dixon E; Haider M; Molinari M; Reinhold C; Sherman M
    AJR Am J Roentgenol; 2015 Mar; 204(3):498-509. PubMed ID: 25714278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.
    Kumar A; Acharya SK; Singh SP; Saraswat VA; Arora A; Duseja A; Goenka MK; Jain D; Kar P; Kumar M; Kumaran V; Mohandas KM; Panda D; Paul SB; Ramachandran J; Ramesh H; Rao PN; Shah SR; Sharma H; Thandassery RB;
    J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S3-S26. PubMed ID: 25755608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2014 KLCSG-NCC Korea Practice Guidelines for the management of hepatocellular carcinoma: HCC diagnostic algorithm.
    Lee JM; Park JW; Choi BI
    Dig Dis; 2014; 32(6):764-77. PubMed ID: 25376295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACG clinical guideline: the diagnosis and management of focal liver lesions.
    Marrero JA; Ahn J; Rajender Reddy K;
    Am J Gastroenterol; 2014 Sep; 109(9):1328-47; quiz 1348. PubMed ID: 25135008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus report from the 6th International forum for liver MRI using gadoxetic acid.
    Sirlin CB; Hussain HK; Jonas E; Kanematsu M; Min Lee J; Merkle EM; Peck-Radosavljevic M; Reeder SB; Ricke J; Sakamoto M
    J Magn Reson Imaging; 2014 Sep; 40(3):516-29. PubMed ID: 24923695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus report of the Fifth International Forum for Liver MRI.
    Zech CJ; Bartolozzi C; Bioulac-Sage P; Chow PK; Forner A; Grazioli L; Huppertz A; Laumonier H; Min Lee J; Murakami T; Ricke J; Sirlin CB
    AJR Am J Roentgenol; 2013 Jul; 201(1):97-107. PubMed ID: 23789662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of Diffusion-Weighted Imaging and Hepatobiliary-Specific Contrast Agent Gd-EOB-DTPA in the Diagnosis and Differential Diagnosis of Focal Liver Lesions].
    Chen GY; Li ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):737-743. PubMed ID: 36224672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West.
    Yen YH; Cheng YF; Wang JH; Lin CC; Chen YY; Yong CC; Liu YW; Cheng JY; Chen CH; Hu TH
    PLoS One; 2020; 15(3):e0230005. PubMed ID: 32163475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Evaluation of Display Contrast of Gd-EOB-DTPA-Enhanced Magnetic Resonance Images: Effects of the Flip Angle and Grayscale Gamma Value.
    Inoue Y; Hata H; Nakajima A; Matsunaga K; Ohzeki Y; Hashimoto T; Haradome H
    Radiol Res Pract; 2019; 2019():7630671. PubMed ID: 30792926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gd-EOB-DTPA dynamic contrast-enhanced magnetic resonance imaging is more effective than enhanced 64-slice CT for the detection of small lesions in patients with hepatocellular carcinoma.
    Li J; Li X; Weng J; Lei L; Gong J; Wang J; Li Z; Zhang L; He S
    Medicine (Baltimore); 2018 Dec; 97(52):e13964. PubMed ID: 30593219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of imaging examinations in patients with primary hepatocellular carcinoma.
    Li XH; Liang Q; Chen TW; Wang J; Zhang XM
    World J Clin Cases; 2018 Sep; 6(9):242-248. PubMed ID: 30211204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image Non-Uniformity Correction for 3-T Gd-EOB-DTPA-Enhanced MR Imaging of the Liver.
    Ogasawara G; Inoue Y; Matsunaga K; Fujii K; Hata H; Takato Y
    Magn Reson Med Sci; 2017 Apr; 16(2):115-122. PubMed ID: 27385553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of gadoxetic acid-enhanced magnetic resonance imaging in surgery for hepatocellular carcinoma - with a special emphasis on early hepatocellular carcinoma.
    Matsuda M
    World J Hepatol; 2015 Dec; 7(30):2933-9. PubMed ID: 26730272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular Carcinoma: Current Concepts in Diagnosis, Staging and Treatment.
    Schütte K; Schulz C; Malfertheiner P
    Gastrointest Tumors; 2014 Jun; 1(2):84-92. PubMed ID: 26672483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.
    Kudo M; Matsui O; Izumi N; Iijima H; Kadoya M; Imai Y; Okusaka T; Miyayama S; Tsuchiya K; Ueshima K; Hiraoka A; Ikeda M; Ogasawara S; Yamashita T; Minami T; Yamakado K;
    Liver Cancer; 2014 Oct; 3(3-4):458-68. PubMed ID: 26280007
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.